+
Site Tour

Search

  • EPIC™ Max Clinical Data

    BUILT ON THE EPIC™PLATFORM THAT HAS STOOD THE TEST OF TIME AT 10 YEARS OVER 11.000 PATIENTS 94.6%* Epic™ Supra Valve Freedom From All-Cause Reintervention2 OVER 1.900 PATIENTS 96.3%* …
  • EPIC™ Max Features

    PORCINE LEAFLETS LOW AORTIC PROTRUSION UNIQUE PERICARDIAL…
  • Patients who benefit

    SURGICAL VALVE TREATMENT FOR MITRAL AORTIC VALVE DISEASE The Epic™ Plus Mitral stented tissue valve is indicated for patients requiring replacement of a diseased, damaged, or malfunctioning native…
  • EPIC™ MAX Overview

    TISSUE HEART VALVES (THV) OPTIMIZE OUTCOMES. REDEFINE POSSIBILITIES. Epic™ Max is designed to refine the future of aortic valve replacement lifetime management by providing unparalleled…
  • Clinical Data

    CLINICALLY PROVEN OUTCOMES Clinical studies continue to show that the Amplatzer™ Valvular Plug III, formerly known as AVP III, is a highly effective solution in closing PVLs near mechanical surgical…
  • Key Features

    BUILT ON THE EXTENSIVE AMPLATZER™ LEGACY OF SAFETY AND EFFICACY Pioneered transcatheter cardiovascular and peripheral vascular occlusion Over 1.25 million Amplatzer™ devices implanted worldwide9…
  • Patients who benefit

    A SOLUTION TO A KEY ISSUE Around the world, PVLs are a common and challenging problem, occurring in 7% to 17% of mitral valve replacements (MVRs) and 5% to 10% of aortic valve replacements (AVRs).1…
  • Overview

    DELIVERING AN EFFECTIVE SOLUTION FOR A WIDE RANGE OF PVL MORPHOLOGIES2,6,7 Paravalvular leaks (PVLs) can be found in a variety of shapes and sizes. To tackle the leaks and fill the gaps of different…
  • Clinical Data

    SWITCH TO THE interventional VIEW    For more information specific to interventional cardiology regarding PDA closure CAP=continued access protocol, IDE=investigational device…
  • Recommendations

    SWITCH TO THE interventional VIEW    For more information specific to interventional cardiology regarding PDA closure When an infant is asymptomatic or well controlled on medical…

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline